Wire
UBS Trims Price Target on Syndax Pharmaceuticals to $37 From $38, Maintains Buy Rating
Syndax Pharmaceuticals (SNDX) has an average rating of buy and mean price target of $39.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $20.29, Change: $-0.12, Percent Change: -0.59%
$SNDX
